Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Pathological Response Rate
Interventions: DRUG: vectibix|DRUG: fluorouracile|DRUG: Epirubicine|DRUG: cyclophosphamide|DRUG: docetaxel
Sponsor: Centre Jean Perrin